Top Markets
Coin of the day
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc.

BBOT
Rang în acțiuni #11444
BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical... BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical firm dedicated to pioneering advanced small molecule treatments. These therapies are aimed at combating malignancies driven by RAS and PI3Kα, both frequently encountered oncogenes in human cancers. Initially established as an offshoot of BridgeBio Pharma, the company concentrates on precision oncology. Its developmental pipeline features several promising programs, including BBO-8520, BBO-10203, and BBO-11818, all specifically designed to modulate the KRAS and PI3K pathways. The company recently became publicly traded through a business combination with Helix Acquisition Corp. II. This strategic move successfully raised approximately $450 million, which will be utilized to further its clinical development initiatives. The leadership team comprises Dr. Eli Wallace as Chief Executive Officer and Dr. Pedro Beltran as Chief Scientific Officer.
Preț acțiune
$8.74
Ultima sincronizare: 2026-08-28
Capitalizare de piață
$699.74M
Schimbare (1 zi)
-4.85%
Schimbare (1 an)
-2.29%
Țară
US
Tranzacționează BridgeBio Oncology Therapeutics Inc. (BBOT)

Categorie

Istoricul spliturilor pentru BridgeBio Oncology Therapeutics Inc. (BBOT)
Acțiunea BridgeBio Oncology Therapeutics Inc. (simbol: BBOT) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 30, 2026.
O acțiune BBOT cumpărată înainte de Aug 30, 2026 este echivalentă astăzi cu 0 acțiuni BBOT.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH